Genomic Mining Limited - Period Ending 2015-03-31

Genomic Mining Limited - Period Ending 2015-03-31


Genomic Mining LimitedNI039951truefalse2014-04-012015-03-312015-03-31NI0399512014-04-012015-03-31NI0399512015-03-31NI039951uk-bus:OrdinaryShareClass12015-03-31NI039951uk-bus:OrdinaryShareClass22015-03-31NI039951uk-bus:PreferenceShareClass12015-03-31NI039951uk-bus:Director32014-04-012015-03-31NI039951uk-bus:OrdinaryShareClass12014-04-012015-03-31NI039951uk-bus:OrdinaryShareClass22014-04-012015-03-31NI039951uk-bus:PreferenceShareClass12014-04-012015-03-31NI039951uk-bus:EntityAccountantsOrAuditors2014-04-012015-03-31NI0399512014-03-31NI0399512014-03-31NI039951uk-bus:OrdinaryShareClass12014-03-31NI039951uk-bus:OrdinaryShareClass22014-03-31NI039951uk-bus:PreferenceShareClass12014-03-31iso4217:GBPxbrli:shares

Registration number: NI039951

Genomic Mining Limited

Annual Report and Unaudited Accounts

for the Year Ended 31 March 2015
 

Duffy & Co (A & T) Ltd
Chartered Accountants
126 Eglantine Avenue
Belfast
Co Antrim
BT9 6EU

 

Genomic Mining Limited
(Registration number: NI039951)
Balance Sheet at 31 March 2015

   

Note

   

2015
£

   

2014
£

 

Current assets

 

             

Debtors

 

2

   

4

   

4

 

Cash at bank and in hand

 

   

380

   

380

 
   

   

384

   

384

 

Creditors: Amounts falling due within one year

 

3

   

(15,774)

   

(15,774)

 

Net liabilities

 

   

(15,390)

   

(15,390)

 

Capital and reserves

 

             

Called up share capital

 

4

   

50,504

   

50,504

 

Profit and loss account

 

   

(65,894)

   

(65,894)

 

Shareholders' deficit

 

   

(15,390)

   

(15,390)

 

For the year ending 31 March 2015 the company was entitled to exemption under section 480 of the Companies Act 2006 relating to dormant companies.

These accounts have been prepared in accordance with the provisions applicable to companies subject to the small companies regime and in accordance with the Financial Reporting Standard for Smaller Entities (effective 2008).

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

Approved and authorised for issue by the Board on 27 April 2015 and signed on its behalf by:

.........................................
Dr Paul Harkin
Director

The notes on page 2 form an integral part of these financial statements.
Page 1

 

Genomic Mining Limited
Notes to the financial statements for the Year Ended 31 March 2015
......... continued

1

Accounting policies

Trading status

The company was dormant and has not traded during the year.

Financial instruments

Financial instruments are classified and accounted for, according to the substance of the contractual arrangement, as financial assets, financial liabilities or equity instruments. An equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all of its liabilities. Where shares are issued, any component that creates a financial liability of the company is presented as a liability in the balance sheet. The corresponding dividends relating to the liability component are charged as interest expense in the profit and loss account.

2

Debtors

   

2015
£

   

2014
£

 
             

Other debtors

 

4

   

4

 

3

Creditors: Amounts falling due within one year

   

2015
£

   

2014
£

 
             

Trade creditors

 

4,854

   

4,854

 

Other creditors

 

10,920

   

10,920

 
   

15,774

   

15,774

 

4

Share capital

Allotted, called up and fully paid shares

 

2015

2014

   

No.

   

£

   

No.

   

£

 

A Ordinary of £0.10 each

 

200,040

   

20,004

   

200,040

   

20,004

 

B Ordinary of £0.10 each

 

190,000

   

19,000

   

190,000

   

19,000

 

A Convertible cumulative redeemable preference of £1 each

 

11,500

   

11,500

   

11,500

   

11,500

 
   

401,540

   

50,504

   

401,540

   

50,504